Extract
We have read with great interest the study by Huitema et al. [1] showing a pulmonary hypertension (PH) prevalence of around 3% in a large cohort of predominantly Caucasian sarcoidosis patients in a Dutch tertiary centre. According to the authors, a European Caucasian cohort has never been studied before this PULmonary hypertension in pulmonary SARcoidosis (PULSAR) study. In this context, in 2013 we reported another PULSAR study (PULmonary hypertension in SARcoidosis) in an albeit smaller cohort from a German tertiary centre [2]. Of interest, we showed very similar results, with a prevalence of precapillary PH of 3.6% with a similar study design in Caucasian sarcoidosis patients.
Abstract
A cumulative analysis of both PULSAR trials would demonstrate sarcoidosis-associated pulmonary hypertension proven by right heart catheter in 15/510 patients and precapillary PH in 13/510 patients http://bit.ly/34VGWbv
Footnotes
Conflict of interest: S. Pabst has nothing to disclose.
Conflict of interest: C. Grohé has nothing to disclose.
Conflict of interest: D. Skowasch has nothing to disclose.
- Received November 18, 2019.
- Accepted December 17, 2019.
- Copyright ©ERS 2020
INDIVIDUALS
Log in using your username and password
LIBRARY USERS
Log in through your institution
Purchase access
CONTACT US
If you have any questions about the ERS publications website, please contact journals@ersnet.org